Tag: Anchor Capital

Tech giants report strong earnings

The big four tech giants, worth nearly $5 trillion reported earnings last week defying the worst economic downturns on record. Joining CNBC Africa for more on the numbers is Henry Biddlecombe, Analyst at Anchor Capital.

COVID-19: Anchor Capital’s outlook for SA companies

The current state of the global and local economy has seen many companies deferring dividend payments and initiating capital raising plans to ensure sustainability of its business. Joining CNBC Africa for more on these companies’ processes and a shareholders outlook is Stephán Engelbrecht, Fund Manager at Anchor Capital.

Is it time to buy the crash?

The last month has seen the most brutal stock market crash that most investors have experienced. Is it time to buy the crash? Peter Armitage, CEO and Co-Chief Investment Officer at Anchor Capital joins CNBC Africa for more.

How to COVID-19 proof your investment portfolio

With markets gyrating because of COVID-19, what should you be doing with your portfolio? Which shares should you be investing in? In this special we find out.

How China’s coronavirus impacts Richemont, other JSE-listed companies

Chinese markets tumbled upon its return from the extended Lunar New Year holiday following the global crisis of the Coronavirus. Joining CNBC Africa for more on this and the industries set to be affected by the virus outbreak is Stephan Engelbrecht, Fund Manager at Anchor Capital.

SA’s economic woes & its impact on JSE listed local companies

According to Peter Little, Fund Manager at Anchor Capital, South Africa has not experienced a lost decade but rather the last 5 years has been tough on domestically focused South African companies on the JSE due to economic pressures.

Where Anchor Capital is putting its money in 2020

Anchor Capital’s strategy and asset allocation for the first quarter of 2020 is out. The asset manager says the global economic expansion has surpassed what many expected and fears of a recession have receded. However, not all countries are benefiting equally, and it appears that this year will see greater gains in emerging markets than in developed nations. Nolan Wapenaar, Fund manager, Anchor Capital joins CNBC Africa for more.

Blue Label impairs Cell C investment to nil for year end, is it time to buy?

With both Net1 & Blue Label impairing their Cell C investment to nil for their year ends, CNBC Africa’s Fifi Peters asked Henry Biddlecombe, an Analyst at Anchor Capital, whether he would be buying Blue Label?
Advertisment